Generative artificial intelligence for small molecule drug design
Current Opinion in Biotechnology · 2024
DOI: 10.1016/j.copbio.2024.103175 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Opinion in Biotechnology, 2024. Verfasst von Ganesh Chandan Kanakala und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Computational Natural Sciences and Bioinformatics, International Institute of Information Technology, Hyderabad 500032, Telangana, India. Hauptthemen laut MEDLINE: Artificial Intelligence, Drug Design. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Indraprastha Institute of Information Technology, Delhi, Department of Science and Technology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
In recent years, the rapid advancement of generative artificial intelligence (GenAI) has revolutionized the landscape of drug design, offering innovative solutions to potentially expedite the discovery of novel therapeutics. GenAI encompasses algorithms and models that autonomously create new data, including text, images, and molecules, often mirroring characteristics of existing datasets. This comprehensive review delves into the realm of GenAI for drug design, emphasizing recent advancements and methodologies that have propelled the field forward. Specifically, we focus on three prominent paradigms: transformers, diffusion models, and reinforcement learning algorithms, which have been exceptionally impactful in the last few years. By synthesizing insights from a myriad of studies and developments, we elucidate the potential of these approaches in accelerating the drug discovery process. Through a detailed analysis, we explore the current state and future directions of GenAI in the context of drug design, highlighting its transformative impact on pharmaceutical research and development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Computational Natural Sciences and Bioinformatics, International Institute of Information Technology, Hyderabad 500032, Telangana, India.
- Centre for Computational Natural Sciences and Bioinformatics, International Institute of Information Technology, Hyderabad 500032, Telangana, India. Electronic address: deva@iiit.ac.in.
Förderung
- Indraprastha Institute of Information Technology, Delhi
- Department of Science and Technology, Ministry of Science and Technology, India
Zitieren
APA
Kanakala, G. C., Devata, S., Chatterjee, P., & Priyakumar, U. D. (2024). Generative artificial intelligence for small molecule drug design. Current Opinion in Biotechnology. https://doi.org/10.1016/j.copbio.2024.103175
Vancouver
Kanakala GC, Devata S, Chatterjee P, Priyakumar UD. Generative artificial intelligence for small molecule drug design. Current Opinion in Biotechnology. 2024. doi:10.1016/j.copbio.2024.103175
BibTeX
@article{Kanakala2024,
author = {Kanakala, Ganesh Chandan and Devata, Sriram and Chatterjee, Prathit and Priyakumar, Udaykumar Deva},
title = {Generative artificial intelligence for small molecule drug design},
journal = {Current Opinion in Biotechnology},
year = {2024},
doi = {10.1016/j.copbio.2024.103175}
}
EUVIMED